General Info
John Abele is an Angel investor with an investment range of $5K – $50K and a sweet spot of $25K. His investment focus areas include Medical Devices, Digital Health, Health IT, and Health & Hospital Services for both Pre-seed and Seed stages. He has made investments in companies like Edifii, Groundwork BioAg, InSpace, Biocogniv, Bloomer Health Tech, and Knowledgehook. John Abele’s partnership and collaboration style emphasizes the democratization of information and power, values collaborative leadership, discusses the challenges and qualities required, and highlights the importance of developing collaboration skills in leaders.
Location: Marlborough, MA
Country: United States of America
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: low-active
AI Reasoning: The latest verifiable investment found where John Abele is listed as an investor is Bloomer Tech’s seed round reported March 12, 2020. That investment occurred more than 12 months ago (over five years prior to the reference date). The startup involved: Bloomer Tech.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of John Abele

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
